Clinical Trial Update: Quetiapine Decreases Smoking in Patients With Chronic Schizophrenia [NA]

View source ↗

Summary

A clinical trial update indicates that quetiapine reduces smoking behavior in patients with chronic schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Quetiapine (quetiapine)

Snippet

Sponsor: Arthur P. Noyes Research Foundation | Conditions: Smoking Behavior in Schizophrenia | NA | Status: UNKNOWN